Research map: Beyond monogenic obesity: the unmet need for anti-obesity pharmacotherapy in rare genetic syndromes
Back to the article
Papers in this map
Turner syndrome: mechanisms and management
· Claus Højbjerg Gravholt · 2019 · 358 citations · Cited by this paper
Effect of metreleptin treatment in congenital generalized lipodystrophy: a retrospective analysis from the MENA region
· 2026 · Related
Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial
· Jesús Argente · 2024 · 50 citations · Cited by this paper
An advertising poster of “Aama” a poor french acromegalic giantess sold twice!
· 2026 · Related
The effects of glucagon‐like peptide (GLP)‐1 receptor agonists on weight and glycaemic control in Prader–Willi syndrome: A systematic review
· Nicholas Beng Hui Ng · 2021 · 44 citations · Cited by this paper
4-Methylumbelliferone for type 1 diabetes therapy: evidence for β-cell protection via EGFR/PI3K/Akt signaling
· 2026 · Related
Determinants of pubertal progression and final height in premature pubarche
· 2026 · Related
Glymphatic dysfunction is associated with hyperglycemia-related cortical thinning in patients with type 2 diabetes mellitus
· 2026 · Related
Association of C-reactive protein to albumin ratio with progression of CKD and all-cause mortality in diabetic CKD
· 2026 · Related
Longitudinal trends in general, central, and visceral adiposity indices among women with endometriosis: a population-based study
· 2026 · Related
Oral polychemotherapy to induce remission in newly diagnosed type 2 diabetes: results from a randomized controlled trial
· 2026 · Related
Phase angle and triglyceride-glucose index as biomarkers of glycemic control, body composition and cardiovascular risk in adolescents with type 1 diabetes: a cross-sectional study
· 2026 · Related
Lactobacillus gasseri alleviates type 2 diabetes via modulation of gut microbiota-host metabolic networks
· 2026 · Related
Source: OpenAlex (CC0)